New sleep apnea device aims to keep breathing steady all night

NCT ID NCT07559708

Not yet recruiting Disease control Sponsor: Sleepnet Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called Elara APAP for people with obstructive sleep apnea. The device delivers air pressure to keep the airway open during sleep. About 55 adults who already use an APAP machine will have one night of sleep monitoring to see if the device reduces breathing pauses. The goal is to find out if the device works well enough to manage the condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Elara APAP device (a machine that delivers air pressure to keep the airway open during sleep)
What this could lead to: If successful, this device could offer an effective way to manage obstructive sleep apnea, reducing breathing interruptions and improving sleep quality.
What could go wrong: This is a small, early-stage study (55 people) with no comparison group, so results may not apply to everyone. The device may not work well for all patients or could be uncomfortable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SLEEP APNEA, OBSTRUCTIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SLEEP APNEA, OBSTRUCTIVE

Contacts and locations

Locations

University Sleep Disorders Center

Auburn, Alabama, 36832, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.